Microglia monitor and protect neuronal function through specialized somatic purinergic junctions

  • Csaba Cserép
    Momentum Laboratory of Neuroimmunology, Institute of Experimental Medicine, Budapest, Hungary.
  • Balázs Pósfai
    Momentum Laboratory of Neuroimmunology, Institute of Experimental Medicine, Budapest, Hungary.
  • Nikolett Lénárt
    Momentum Laboratory of Neuroimmunology, Institute of Experimental Medicine, Budapest, Hungary.
  • Rebeka Fekete
    Momentum Laboratory of Neuroimmunology, Institute of Experimental Medicine, Budapest, Hungary.
  • Zsófia I. László
    Szentágothai János Doctoral School of Neuroscience, Semmelweis University, Budapest, Hungary.
  • Zsolt Lele
    Momentum Laboratory of Molecular Neurobiology, Institute of Experimental Medicine, Budapest, Hungary.
  • Barbara Orsolits
    Momentum Laboratory of Neuroimmunology, Institute of Experimental Medicine, Budapest, Hungary.
  • Gábor Molnár
    MTA-SZTE Research Group for Cortical Microcircuits of the Hungarian Academy of Sciences, Department of Physiology, Anatomy and Neuroscience, University of Szeged, Szeged, Hungary.
  • Steffanie Heindl
    Institute for Stroke and Dementia Research, Ludwig-Maximilians-University, Munich, Germany.
  • Anett D. Schwarcz
    Momentum Laboratory of Neuroimmunology, Institute of Experimental Medicine, Budapest, Hungary.
  • Katinka Ujvári
    Momentum Laboratory of Neuroimmunology, Institute of Experimental Medicine, Budapest, Hungary.
  • Zsuzsanna Környei
    Momentum Laboratory of Neuroimmunology, Institute of Experimental Medicine, Budapest, Hungary.
  • Krisztina Tóth
    Momentum Laboratory of Neuroimmunology, Institute of Experimental Medicine, Budapest, Hungary.
  • Eszter Szabadits
    Momentum Laboratory of Neuroimmunology, Institute of Experimental Medicine, Budapest, Hungary.
  • Beáta Sperlágh
    Laboratory of Molecular Pharmacology, Institute of Experimental Medicine, Budapest, Hungary.
  • Mária Baranyi
    Laboratory of Molecular Pharmacology, Institute of Experimental Medicine, Budapest, Hungary.
  • László Csiba
    MTA-DE Cerebrovascular and Neurodegenerative Research Group, Department of Neurology, University of Debrecen, Debrecen, Hungary.
  • Tibor Hortobágyi
    Institute of Pathology, Faculty of Medicine, University of Szeged, Szeged, Hungary.
  • Zsófia Maglóczky
    Human Brain Research Laboratory, Institute of Experimental Medicine, Budapest, Hungary.
  • Bernadett Martinecz
    Momentum Laboratory of Neuroimmunology, Institute of Experimental Medicine, Budapest, Hungary.
  • Gábor Szabó
    Medical Gene Technology Unit, Institute of Experimental Medicine, Budapest, Hungary.
  • Ferenc Erdélyi
    Medical Gene Technology Unit, Institute of Experimental Medicine, Budapest, Hungary.
  • Róbert Szipőcs
    Institute for Solid State Physics and Optics of Wigner RCP, Budapest, Hungary.
  • Michael M. Tamkun
    Department of Biomedical Sciences, Colorado State University, Fort Collins, Colorado, USA.
  • Benno Gesierich
    Institute for Stroke and Dementia Research, Ludwig-Maximilians-University, Munich, Germany.
  • Marco Duering
    Institute for Stroke and Dementia Research, Ludwig-Maximilians-University, Munich, Germany.
  • István Katona
    Momentum Laboratory of Molecular Neurobiology, Institute of Experimental Medicine, Budapest, Hungary.
  • Arthur Liesz
    Institute for Stroke and Dementia Research, Ludwig-Maximilians-University, Munich, Germany.
  • Gábor Tamás
    MTA-SZTE Research Group for Cortical Microcircuits of the Hungarian Academy of Sciences, Department of Physiology, Anatomy and Neuroscience, University of Szeged, Szeged, Hungary.
  • Ádám Dénes
    Momentum Laboratory of Neuroimmunology, Institute of Experimental Medicine, Budapest, Hungary.

抄録

<jats:title>Microglia take control</jats:title> <jats:p> Changes in the activity of microglia, the primary immune cells of the central nervous system, are linked with major human diseases, including stroke, epilepsy, psychiatric disorders, and neurodegeneration. Cserép <jats:italic>et al.</jats:italic> identified a specialized morphofunctional communication site between microglial processes and neuronal cell bodies in the mouse and the human brain (see the Perspective by Nimmerjahn). These junctions are formed at specific areas of the neuronal somatic membranes and possess a distinctive nanoarchitecture and specialized molecular composition linked to mitochondrial signaling. The junctions appear to provide a major site for microglia-neuron communication and may help to mediate the neuroprotective effects of microglia after acute brain injury. </jats:p> <jats:p> <jats:italic>Science</jats:italic> , this issue p. <jats:related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" issue="6477" page="528" related-article-type="in-this-issue" vol="367" xlink:href="10.1126/science.aax6752">528</jats:related-article> ; see also p. <jats:related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" issue="6477" page="510" related-article-type="in-this-issue" vol="367" xlink:href="10.1126/science.aba4472">510</jats:related-article> </jats:p>

収録刊行物

  • Science

    Science 367 (6477), 528-537, 2020-01-31

    American Association for the Advancement of Science (AAAS)

被引用文献 (12)*注記

もっと見る

問題の指摘

ページトップへ